278 related articles for article (PubMed ID: 19218245)
1. Transforming growth factor-{beta}-inducible phosphorylation of Smad3.
Wang G; Matsuura I; He D; Liu F
J Biol Chem; 2009 Apr; 284(15):9663-73. PubMed ID: 19218245
[TBL] [Abstract][Full Text] [Related]
2. Constitutive Smad linker phosphorylation in melanoma: a mechanism of resistance to transforming growth factor-β-mediated growth inhibition.
Cohen-Solal KA; Merrigan KT; Chan JL; Goydos JS; Chen W; Foran DJ; Liu F; Lasfar A; Reiss M
Pigment Cell Melanoma Res; 2011 Jun; 24(3):512-24. PubMed ID: 21477078
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation status at Smad3 linker region modulates transforming growth factor-β-induced epithelial-mesenchymal transition and cancer progression.
Ooshima A; Park J; Kim SJ
Cancer Sci; 2019 Feb; 110(2):481-488. PubMed ID: 30589983
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells.
Liu X; Sun Y; Constantinescu SN; Karam E; Weinberg RA; Lodish HF
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10669-74. PubMed ID: 9380693
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor β-mediated site-specific Smad linker region phosphorylation in vascular endothelial cells.
Kamato D; Rostam MA; Piva TJ; Babaahmadi Rezaei H; Getachew R; Thach L; Bernard R; Zheng W; Little PJ; Osman N
J Pharm Pharmacol; 2014 Dec; 66(12):1722-33. PubMed ID: 25316549
[TBL] [Abstract][Full Text] [Related]
6. Pin1 promotes transforming growth factor-beta-induced migration and invasion.
Matsuura I; Chiang KN; Lai CY; He D; Wang G; Ramkumar R; Uchida T; Ryo A; Lu K; Liu F
J Biol Chem; 2010 Jan; 285(3):1754-64. PubMed ID: 19920136
[TBL] [Abstract][Full Text] [Related]
7. p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts.
Furukawa F; Matsuzaki K; Mori S; Tahashi Y; Yoshida K; Sugano Y; Yamagata H; Matsushita M; Seki T; Inagaki Y; Nishizawa M; Fujisawa J; Inoue K
Hepatology; 2003 Oct; 38(4):879-89. PubMed ID: 14512875
[TBL] [Abstract][Full Text] [Related]
8. Cell biology of Smad2/3 linker region phosphorylation in vascular smooth muscle.
Rezaei HB; Kamato D; Ansari G; Osman N; Little PJ
Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):661-7. PubMed ID: 21883378
[TBL] [Abstract][Full Text] [Related]
9. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K
Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654
[TBL] [Abstract][Full Text] [Related]
10. Flavopiridol Inhibits TGF-
Rostam MA; Shajimoon A; Kamato D; Mitra P; Piva TJ; Getachew R; Cao Y; Zheng W; Osman N; Little PJ
J Pharmacol Exp Ther; 2018 Apr; 365(1):156-164. PubMed ID: 29438988
[TBL] [Abstract][Full Text] [Related]
11. A negative feedback control of transforming growth factor-beta signaling by glycogen synthase kinase 3-mediated Smad3 linker phosphorylation at Ser-204.
Millet C; Yamashita M; Heller M; Yu LR; Veenstra TD; Zhang YE
J Biol Chem; 2009 Jul; 284(30):19808-16. PubMed ID: 19458083
[TBL] [Abstract][Full Text] [Related]
12. Cyclin-dependent kinases regulate the antiproliferative function of Smads.
Matsuura I; Denissova NG; Wang G; He D; Long J; Liu F
Nature; 2004 Jul; 430(6996):226-31. PubMed ID: 15241418
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.
Yuan W; Varga J
J Biol Chem; 2001 Oct; 276(42):38502-10. PubMed ID: 11502752
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts.
Piek E; Ju WJ; Heyer J; Escalante-Alcalde D; Stewart CL; Weinstein M; Deng C; Kucherlapati R; Bottinger EP; Roberts AB
J Biol Chem; 2001 Jun; 276(23):19945-53. PubMed ID: 11262418
[TBL] [Abstract][Full Text] [Related]
16. Smad3 linker phosphorylation attenuates Smad3 transcriptional activity and TGF-β1/Smad3-induced epithelial-mesenchymal transition in renal epithelial cells.
Bae E; Kim SJ; Hong S; Liu F; Ooshima A
Biochem Biophys Res Commun; 2012 Oct; 427(3):593-9. PubMed ID: 23022526
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation.
Kamato D; Burch ML; Piva TJ; Rezaei HB; Rostam MA; Xu S; Zheng W; Little PJ; Osman N
Cell Signal; 2013 Oct; 25(10):2017-24. PubMed ID: 23770288
[TBL] [Abstract][Full Text] [Related]
18. The phosphorylation of the Smad2/3 linker region by nemo-like kinase regulates TGF-β signaling.
Liang J; Zhou Y; Zhang N; Wang D; Cheng X; Li K; Huang R; Lu Y; Wang H; Han D; Wu W; Han M; Miao S; Wang L; Zhao H; Song W
J Biol Chem; 2021; 296():100512. PubMed ID: 33676893
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta and platelet-derived growth factor signal via c-Jun N-terminal kinase-dependent Smad2/3 phosphorylation in rat hepatic stellate cells after acute liver injury.
Yoshida K; Matsuzaki K; Mori S; Tahashi Y; Yamagata H; Furukawa F; Seki T; Nishizawa M; Fujisawa J; Okazaki K
Am J Pathol; 2005 Apr; 166(4):1029-39. PubMed ID: 15793284
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells.
Hayashida T; Decaestecker M; Schnaper HW
FASEB J; 2003 Aug; 17(11):1576-8. PubMed ID: 12824291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
